combination glp 1 and sglt2 Influence of therapy with inhibitors GLP-1 receptor agonists on the management of blood pressure in Japanese patients with diabetes Mechanisms underlying favorable effects of
Description
JCI Insight (2018) 3(23):115
10.1016/j.obpill.2024.100127 11 HansenM

Clinicians and patients alike sometimes overlook the therapys immense potential for supporting heart and kidney health

2830 In addition to its glucose- and weight-lowering efficacy, semaglutide, when used as add-on standard care in patients with T2DM and high cardiovascular disease, was found to be associated with significantly lower risk of cardiovascular death, nonfatal myocardial infarction, stroke and new or worsening nephropathy compared to placebo

Should you consider them for RA
